This inventor holds 12 USPTO granted patents and 12 published patent applications, plus 8 CIPO patents and 11 EPO patents. Top assignee: Fertin Pharma A/s. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Innovations by Kent Albin Nielsen in Nicotine Delivery Systems
Introduction
Kent Albin Nielsen, an inventive mind based in Brande, Denmark, has made significant strides in the field of nicotine delivery systems. With a total of seven patents to his name, his work has focused on creating innovative oral formulations aimed at alleviating nicotine cravings.
Latest Patents
Nielsen's latest patents include a novel nicotine tablet that is water-dissolvable. This tablet contains a first compressed module, known as the FDT-module, which comprises nicotine, an alkaline pH regulating agent, and a disintegrant. Additionally, it features a second compressed module, termed the lozenge-module, which incorporates an acidic pH regulating agent. This innovative design not only enhances the delivery of nicotine but also offers a method of manufacturing these tablets. Another notable patent involves an oral nicotine formulation that provides an effective peak saliva concentration of nicotine greater than 0.3 mg/mL and a peak saliva pH exceeding 7.5 during the initial 120 seconds after administration. These advancements have the potential to transform how nicotine cravings are managed.
Career Highlights
Nielsen works at Fertin Pharma A/S, a company renowned for its commitment to advancing nicotine delivery methods and oral health solutions. His experience and innovations in this field underline his expertise and dedication to improving consumer products.
Collaborations
Throughout his career, Kent Albin Nielsen has collaborated with notable colleagues, including Bruno Provstgaard Nielsen and Dorthe Schackinger Boesen. These partnerships foster a creative environment that encourages the development of cutting-edge solutions in nicotine delivery systems.
Conclusion
Kent Albin Nielsen's contributions to the field of nicotine formulation demonstrate his innovative spirit and commitment to enhancing user experience. His patents reflect a deep understanding of both pharmacology and consumer needs, positioning him as a significant figure in the ongoing evolution of nicotine products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile